Skip to content
Menu

Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $45

Benzinga Newsdesk 11 hours ago

Analyst RatingsNewsReiterationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight and raises the price target from $30 to $45.

Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight and raises the price target from $30 to $45.

Read at benzinga.com